Multi-Compound Nutraceutical Compositions for Lower-Dose Autophagy Enhancement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing pharmacological autophagy inducers have off-target effects and require supraphysiological dosages, limiting their therapeutic effectiveness for enhancing autophagy, while nutraceuticals face challenges in achieving desired effects at practical concentrations.
Innovation Solution
Development of synergistic combinations of naturally occurring bioactive food compounds, such as saccharides, vitamins, polyphenols, and methylxanthines, administered at subtherapeutic doses to enhance autophagy effectively.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pharmacological autophagy inducers are used, then autophagy enhancement is achieved, but off-target effects occur and supraphysiological dosages are required
Solution Approach 1:
The patent combines multiple nutraceutical compounds (resveratrol, quercetin, epigallocatechin gallate, curcumin, and other polyphenols) into a synergistic formulation. Each compound individually has limited autophagy-inducing capacity at safe doses, but their combination produces enhanced autophagy activation with reduced off-target effects compared to pharmacological agents alone.
Solution Approach 2:
The invention creates a composite nutraceutical formulation integrating multiple bioactive compounds from different chemical classes (polyphenols, flavonoids, stilbenes, terpenes). This composite approach leverages the complementary mechanisms of each compound to achieve reliable autophagy enhancement while maintaining safety profiles.
2Reliability
If single high-dose nutraceutical agents are used to enhance autophagy, then therapeutic effects are achieved, but the dosages become supraphysiological and impractical
Solution Approach 1:
The patent formulates multiple nutraceutical compounds in specific combinations where each component is present at physiologically achievable concentrations. The synergistic interaction among compounds (resveratrol, quercetin, EGCG, curcumin, etc.) allows the formulation to achieve therapeutic autophagy enhancement effects without requiring supraphysiological doses of any single agent.
3Quantity of substance
If combinations of multiple nutraceutical compounds are used, then synergistic autophagy enhancement is achieved at lower dosages, but the formulation complexity increases
Solution Approach 1:
The patent develops a multi-functional nutraceutical formulation where a fixed combination of compounds (resveratrol, quercetin, epigallocatechin gallate, curcumin, and additional polyphenols) works synergistically to activate autophagy through multiple pathways. This universal formulation can be applied to prevent and treat various age-related diseases (neurodegenerative disorders, cardiovascular disease, metabolic syndrome) without requiring customization, thereby managing complexity while delivering synergistic effects.
Data Source
AI summary
Provided are methods for treating a disease or condition associated with reduced autophagy in a patient, which includes administering to the patient, either simultaneously or sequentially, a therapeutically effective amount of a synergistic combination of compounds from at least two and preferably three of the classes of compounds selected from a saccharide, a vitamin, a ketone body, a polyphenol, and a methylxanthine. The compounds may be present in a subtherapeutic effective amount relative to the compound's dosing when given as a single agent. Also provided are pharmaceutically acceptable compositions and kits including at least two and preferably three of the named classes of compounds.